Meta控告AI應用程式香港開發商 製作虛假裸照
Meta(META.US)日前入稟控告一間推廣AI「裸體」應用程式CrushAI ,指該應用程式允許用戶在未經本人同意的情況下,創建由人工智能生成的裸照或色情圖片。
CrushAI開發商為香港企業Joy Timeline HK,Meta稱其在Facebook及Instagram投放大量廣告,利用人工智能在未經同意下製作虛假性愛圖片,圖片可用於性勒索、敲詐和虐待。
Meta表示已與該公司展開多月拉鋸戰,現決定透過法律手段全面禁止對方在其平台投放廣告。根據科技部落格FakedUp統計,今年1月就錄得8,010宗CrushAI相關廣告出現於Meta平台上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.